SCHEMBL4867447

SCHEMBL4867447

Cc1cccc(-c2nn3ccccc3c2C2=COC=C(C3=CC=CCC3)O2)n1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 10/20 0.32
THRB P10828 5/20 0.32
MAPK14 Q16539 3/20 0.31
TGFBR2 P37173 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2044548 0.78 METAP2 (0.33)
SCHEMBL6808735 0.76 TGFBR1 (0.33) TGFBR1TGFBR2
SCHEMBL6601320 0.74 CYP2D6 (0.31) TGFBR1TGFBR2
SCHEMBL5139233 0.74
SCHEMBL6917532 0.74 TGFBR1 (0.31) TGFBR1TGFBR2
SCHEMBL14576882 0.72 TGFBR1 (0.48) TGFBR1
SCHEMBL4873701 0.70 AKT1 (0.46) TGFBR1THRBMAPK14TGFBR2
SCHEMBL3441964 0.69 SLC2A1 (0.40)
SCHEMBL4862130 0.68 TGFBR1 (0.53) TGFBR1THRBMAPK14TGFBR2
SCHEMBL6390141 0.67 RAB9A (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365066-B2 Pyrazolopyridine derivatives as pharmaceutical agents ELI LILLY AND COMPANY (US) 2008-04-29 US claimed
EP-1543001-B1 PYRAZOLOPYRIDINE DERIVATIVES AS TGF BETA SIGNAL TRANSDUCTION INHIBITORS FOR THE TREATMENT OF CANCER LILLY CO ELI (US) 2007-08-15 EP disclosed